UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051638
Receipt number R000058924
Scientific Title The effect of ingestion of eicosapentaenoic acid and docosahexaenoic acid on blood triglyceride - A systematic review
Date of disclosure of the study information 2023/07/18
Last modified on 2023/07/18 18:39:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of ingestion of eicosapentaenoic acid and docosahexaenoic acid on blood triglyceride - A systematic review

Acronym

Effect of EPA and DHA on blood triglyceride - A systematic review

Scientific Title

The effect of ingestion of eicosapentaenoic acid and docosahexaenoic acid on blood triglyceride - A systematic review

Scientific Title:Acronym

Effect of EPA and DHA on blood triglyceride - A systematic review

Region

Japan


Condition

Condition

Healthy adults and those with slightly higher fasting blood triglyceride levels

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate the effect of ingestion of EPA and DHA on blood triglyceride.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood triglyceride

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Healthy adults and those with slightly higher fasting blood triglyceride levels

Key exclusion criteria

Participants who are suffering from illness and less than 18 years and pregnant

Target sample size



Research contact person

Name of lead principal investigator

1st name Norikazu
Middle name
Last name Watanabe

Organization

Yakujihou Marketing Jimusho Co., Ltd.

Division name

Not Applicable

Zip code

100-6103

Address

Level 3, Sanno Park Tower, Nagatacho 2-11-1, Chiyoda-ku, Tokyo

TEL

03-6205-3546

Email

watanabe@yakujihou-marketing.co.jp


Public contact

Name of contact person

1st name Kenichi
Middle name
Last name Yanagimoto

Organization

Nissui Corporation

Division name

Food function R and D center

Zip code

105-0003

Address

Nishishinbashi 1-3-1, Minato-ku, Tokyo

TEL

080-2098-2093

Homepage URL


Email

yanagimoto@nissui.co.jp


Sponsor or person

Institute

Nissui Corporation

Institute

Department

Personal name



Funding Source

Organization

Nissui Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Not Applicable

Address

Not Applicable

Tel

Not Applicable

Email

Not Applicable


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 07 Month 07 Day

Date of IRB


Anticipated trial start date

2023 Year 07 Month 18 Day

Last follow-up date

2023 Year 09 Month 17 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Nothing


Management information

Registered date

2023 Year 07 Month 18 Day

Last modified on

2023 Year 07 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058924


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name